Haemoconcentration during treatment of acute heart failure with cardiorenal syndrome: from the CARRESS-HF trial

Eur J Heart Fail. 2019 Nov;21(11):1472-1476. doi: 10.1002/ejhf.1592. Epub 2019 Aug 27.

Authors

Vanessa Blumer¹, Stephen J Greene^{1

2}, Jie-Lena Sun², Bradley A Bart³, Andrew P Ambrosy^{4

5}, Javed Butler⁶, Adam D DeVore^{1

2}, Marat Fudim^{1

2}, Adrian F Hernandez^{1

2}, Steven E McNulty², G Michael Felker^{1

2}, Robert J Mentz^{1

2}

Affiliations

¹ Division of Cardiology, Duke University Medical Center, Durham, NC, USA.
² Duke Clinical Research Institute, Durham, NC, USA.
³ Division of Cardiology, Hennepin County Medical Center, Minneapolis, MN, USA.
⁴ Division of Cardiology, The Permanente Medical Group, San Francisco, CA, USA.
⁵ Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
⁶ Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.

PMID: 31452311
DOI: 10.1002/ejhf.1592

No abstract available

Publication types

Letter
Multicenter Study
Randomized Controlled Trial
Research Support, N.I.H., Extramural

MeSH terms

Acute Disease
Aged
Cardio-Renal Syndrome / blood
Cardio-Renal Syndrome / therapy*
Comorbidity
Female
Heart Failure / blood
Heart Failure / therapy*
Hematocrit*
Hemofiltration*
Hemoglobinometry*
Hospitalization
Humans
Kidney Function Tests
Male
Middle Aged

Grants and funding